Finance

Lists
002728:SHE
Teyi Pharmaceutical Group Co Ltd
CNÂ¥9,71
-0,21%
(-0,020) 1D
14 Okt., 15:04:06 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002728...
Open
CNÂ¥9,69
High
CNÂ¥9,83
Low
CNÂ¥9,58
Mkt. cap
4,99 mjd
Avg. vol.
18,94 m
Volume
14,47 m
Dividend
1,54%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
18 Jun. 2026
P/E ratio
69,59
52-wk high
CNÂ¥15,21
52-wk low
CNÂ¥7,66
EPS
CNÂ¥0,14
Shares outstanding
513,31 m
No. of employees
1 k
Open
CNÂ¥9,69
High
CNÂ¥9,83
Low
CNÂ¥9,58
Mkt. cap
4,99 mjd
Avg. vol.
18,94 m
Volume
14,47 m
Dividend
1,54%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
18 Jun. 2026
P/E ratio
69,59
52-wk high
CNÂ¥15,21
52-wk low
CNÂ¥7,66
EPS
CNÂ¥0,14
Shares outstanding
513,31 m
No. of employees
1 k
News stories
From web sources and news partners
About Teyi Pharmaceutical Group Co Ltd
CEO-
Employees1,43 k
Founded23 Mei 2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
200,71 m
232,68 m
209,87 m
183,45 m
Cost of goods sold
102,58 m
123,26 m
81,88 m
87,55 m
Cost of revenue
102,58 m
123,26 m
81,88 m
87,55 m
Research and development expenses
11,06 m
14,19 m
9,25 m
11,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62,18 m
83,64 m
85,27 m
75,71 m
Operating expense
73,02 m
102,76 m
93,09 m
88,23 m
Total operating expenses
175,60 m
226,01 m
174,97 m
175,78 m
Operating income
25,11 m
6,67 m
34,91 m
7,67 m
Other non operating income
-755,83 k
604,89 k
-33,22 k
-206,21 k
EBT including unusual items
26,78 m
7,45 m
35,14 m
7,17 m
EBT excluding unusual items
24,81 m
7,29 m
35,61 m
7,09 m
Income tax expense
-433,06 k
-9,00 m
9,37 m
1,83 m
Effective tax rate
-1,62%
-120,80%
26,67%
25,48%
Other operating expenses
193,29 k
4,17 m
-340,24 k
1,34 m
Net income
27,21 m
16,45 m
25,76 m
5,34 m
Net profit margin
13,56%
7,07%
12,28%
2,91%
Earnings per share
-
-
-
-
Interest and investment income
1,03 m
601,98 k
1,52 m
859,16 k
Interest expense
-579,01 k
-579,51 k
-775,84 k
-1,24 m
Net interest expenses
449,92 k
22,46 k
742,40 k
-376,54 k
Depreciation and amortization charges
-
-
-
-
EBITDA
41,20 m
24,12 m
52,36 m
26,35 m
Gain or loss from assets sale
-83,37 k
68,45 k
-
-802,00
AI content may include mistakes. Learn more
Google-programme